These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20571425)

  • 1. Community engagement and investment in biomedical HIV prevention research for youth: rationale, challenges, and approaches.
    Ellen JM; Wallace M; Sawe FK; Fisher K
    J Acquir Immune Defic Syndr; 2010 Jul; 54 Suppl 1():S7-11. PubMed ID: 20571425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trouble with difference: Challenging and reproducing inequality in a biomedical HIV research community engagement process.
    de Wet A; Swartz L; Kagee A; Lesch A; Kafaar Z; Hassan NR; Robbertze D; Newman PA
    Glob Public Health; 2020 Jan; 15(1):22-30. PubMed ID: 31274374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.
    Broder GB; Lucas JP; Davis J; Wallace SE; Luthuli N; Baepanye K; White RR; Bolton M; Blanchette C; Andrasik MP
    PLoS One; 2020; 15(9):e0239276. PubMed ID: 32941520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study.
    Newman PA; Rubincam C; Slack C; Essack Z; Chakrapani V; Chuang DM; Tepjan S; Shunmugam M; Roungprakhon S; Logie C; Koen J; Lindegger G
    PLoS One; 2015; 10(8):e0135937. PubMed ID: 26295159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials.
    Kagee A; De Wet A; Kafaar Z; Lesch A; Swartz L; Newman PA
    J Health Psychol; 2020 Jan; 25(1):82-91. PubMed ID: 29243520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence.
    Newman PA; Rubincam C
    Expert Rev Vaccines; 2014 Dec; 13(12):1553-62. PubMed ID: 25174764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening community engagement in clinical research: Designing and assessing a pilot crowdsourcing project to obtain community feedback on an HIV clinical trial.
    Day S; Mathews A; Blumberg M; Vu T; Rennie S; Tucker JD
    Clin Trials; 2020 Jun; 17(3):306-313. PubMed ID: 32009466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges to conducting HIV preventative vaccine trials with adolescents.
    McClure CA; Gray G; Rybczyk GK; Wright PF
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):726-33. PubMed ID: 15167292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to adolescents' participation in HIV biomedical prevention research.
    DiClemente RJ; Ruiz MS; Sales JM
    J Acquir Immune Defic Syndr; 2010 Jul; 54 Suppl 1(Suppl 1):S12-7. PubMed ID: 20571418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials.
    Essack Z; Koen J; Slack C; Lindegger G; Newman PA
    AIDS Care; 2012; 24(10):1249-54. PubMed ID: 22360605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives.
    Moodley K; Staunton C; de Roubaix M; Cotton M
    AIDS Care; 2016; 28(4):524-7. PubMed ID: 26565595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involving vulnerable populations of youth in HIV prevention clinical research.
    Borek N; Allison S; Cáceres CF
    J Acquir Immune Defic Syndr; 2010 Jul; 54 Suppl 1():S43-9. PubMed ID: 20571422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral considerations for engaging youth in HIV clinical research.
    Hosek SG; Zimet GD
    J Acquir Immune Defic Syndr; 2010 Jul; 54 Suppl 1():S25-30. PubMed ID: 20571420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building Partnerships and Stakeholder Relationships for HIV Prevention: Longitudinal Cohort Study Focuses on Community Engagement.
    DeShields RD; Lucas JP; Turner M; Amola K; Hunter V; Lykes S; Rompalo AM; Vermund SH; Fischer S; Haley DF
    Prog Community Health Partnersh; 2020; 14(1):29-42. PubMed ID: 32280121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A situational analysis methodology to inform comprehensive HIV prevention and treatment programming, applied in rural South Africa.
    Treves-Kagan S; Naidoo E; Gilvydis JM; Raphela E; Barnhart S; Lippman SA
    Glob Public Health; 2017 Sep; 12(9):1122-1140. PubMed ID: 26414798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing common ground in community-based arts in health.
    White M
    J R Soc Promot Health; 2006 May; 126(3):128-33. PubMed ID: 16739618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Community Change Outcomes of the Connect-to-Protect Coalitions: Trials and Triumphs Securing Adolescent Access to HIV Prevention, Testing, and Medical Care.
    Miller RL; Reed SJ; Chiaramonte D; Strzyzykowski T; Spring H; Acevedo-Polakovich ID; Chutuape K; Cooper-Walker B; Boyer CB; Ellen JM
    Am J Community Psychol; 2017 Sep; 60(1-2):199-214. PubMed ID: 28851064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials.
    Koen J; Essack Z; Slack C; Lindegger G; Newman PA
    Dev World Bioeth; 2013 Dec; 13(3):138-48. PubMed ID: 22998395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster randomized trial of community mobilization to reduce methamphetamine use and HIV risk among youth in Thailand: Design, implementation and results.
    Galai N; Sirirojn B; Aramrattana A; Srichan K; Thomson N; Golozar A; Flores JM; Willard N; Ellen JM; Sherman SG; Celentano DD
    Soc Sci Med; 2018 Aug; 211():216-223. PubMed ID: 29966816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.